The Current Ratio as of September 2024 (TTM) for Mustang Bio, Inc. (MBIO) is 0.46

According to Mustang Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.46. This represents a change of -31.57% compared to the average of 0.67 of the last 4 quarters.

Mustang Bio, Inc. (MBIO) Historical Current Ratio (quarterly & annually)

How has MBIO Current Ratio performed in the past?

The mean historical Current Ratio of Mustang Bio, Inc. over the last ten years is 7.40. The current 0.46 Current Ratio has changed 520.78% with respect to the historical average. Over the past ten years (40 quarters), MBIO's Current Ratio was at its highest in in the March 2017 quarter at 92.51. The Current Ratio was at its lowest in in the September 2015 quarter at 0.

Mustang Bio, Inc. (MBIO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Mustang Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mustang Bio, Inc. (MBIO) Average Current Ratio

How has MBIO Current Ratio performed in the past?

The current Current Ratio of Mustang Bio, Inc. (MBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Mustang Bio, Inc. (MBIO) Current Ratio vs. Peers

How is MBIO’s Current Ratio compared to its peers?

Mustang Bio, Inc.’s Current Ratio is greater than Checkpoint Therapeutics, Inc. (0.26), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), less than Fortress Biotech, Inc. (1.37), less than Kodiak Sciences Inc. (10.59), less than Fortress Biotech, Inc. (1.37), less than Achilles Therapeutics plc (8.24), less than Aptose Biosciences Inc. (0.80), greater than Aditxt, Inc. (0.07), less than NeuroBo Pharmaceuticals, Inc. (2.94), less than Dermata Therapeutics, Inc. (2.73), less than Unicycive Therapeutics, Inc. (3.37), less than Revelation Biosciences, Inc. (1.10), less than Affimed N.V. (2.71), less than Leap Therapeutics, Inc. (5.10), less than Adaptimmune Therapeutics plc (3.09), less than Corvus Pharmaceuticals, Inc. (3.62), less than Akari Therapeutics, Plc (0.58), less than Salarius Pharmaceuticals, Inc. (2.98), less than Axcella Health Inc. (0.80), less than Magenta Therapeutics, Inc. (14.64), less than Histogen Inc. (4.05),

Build a custom stock screener for Mustang Bio, Inc. (MBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mustang Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mustang Bio, Inc. (MBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mustang Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.